Irene C. Souter, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Infertility, Female | 28 | 2023 | 784 | 5.010 |
Why?
|
Insemination, Artificial | 13 | 2023 | 98 | 4.680 |
Why?
|
Ovulation Induction | 13 | 2023 | 274 | 4.400 |
Why?
|
Infertility | 20 | 2023 | 649 | 3.530 |
Why?
|
Pregnancy Rate | 32 | 2023 | 642 | 2.930 |
Why?
|
Fertilization in Vitro | 31 | 2023 | 1283 | 2.650 |
Why?
|
Anti-Mullerian Hormone | 9 | 2023 | 399 | 2.620 |
Why?
|
Polycystic Ovary Syndrome | 5 | 2022 | 365 | 2.070 |
Why?
|
Ovarian Follicle | 13 | 2023 | 247 | 1.890 |
Why?
|
Phthalic Acids | 11 | 2023 | 433 | 1.780 |
Why?
|
Abortion, Spontaneous | 13 | 2023 | 526 | 1.730 |
Why?
|
Reproductive Techniques, Assisted | 19 | 2022 | 483 | 1.650 |
Why?
|
Pregnancy Outcome | 22 | 2023 | 2789 | 1.500 |
Why?
|
Blastocyst | 9 | 2023 | 424 | 1.480 |
Why?
|
Follicle Stimulating Hormone | 14 | 2023 | 739 | 1.400 |
Why?
|
Fertility Agents, Female | 6 | 2022 | 99 | 1.240 |
Why?
|
Phenols | 10 | 2023 | 499 | 1.240 |
Why?
|
Live Birth | 18 | 2022 | 512 | 1.190 |
Why?
|
Environmental Pollutants | 10 | 2024 | 1172 | 1.180 |
Why?
|
Gonadotropins | 4 | 2021 | 241 | 1.050 |
Why?
|
Pregnancy | 74 | 2024 | 29002 | 1.010 |
Why?
|
Semen | 8 | 2023 | 316 | 1.000 |
Why?
|
Diethylhexyl Phthalate | 5 | 2023 | 81 | 0.940 |
Why?
|
Pregnancy, Multiple | 4 | 2019 | 217 | 0.940 |
Why?
|
Semen Analysis | 7 | 2023 | 204 | 0.920 |
Why?
|
Embryo Culture Techniques | 2 | 2021 | 80 | 0.880 |
Why?
|
Follicular Phase | 3 | 2019 | 153 | 0.860 |
Why?
|
Thyroid Gland | 2 | 2020 | 1169 | 0.850 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2020 | 30 | 0.760 |
Why?
|
Anovulation | 1 | 2020 | 58 | 0.760 |
Why?
|
Benzhydryl Compounds | 7 | 2022 | 819 | 0.710 |
Why?
|
Embryo Transfer | 9 | 2022 | 510 | 0.700 |
Why?
|
Follicular Fluid | 4 | 2023 | 87 | 0.670 |
Why?
|
Dairy Products | 3 | 2017 | 498 | 0.660 |
Why?
|
Endometrium | 3 | 2019 | 425 | 0.640 |
Why?
|
Fertility | 10 | 2023 | 775 | 0.620 |
Why?
|
Parabens | 5 | 2023 | 108 | 0.590 |
Why?
|
Decision Support Techniques | 3 | 2022 | 1957 | 0.560 |
Why?
|
Embryo Implantation | 7 | 2022 | 272 | 0.530 |
Why?
|
Fathers | 5 | 2024 | 357 | 0.500 |
Why?
|
Maternal Exposure | 5 | 2021 | 952 | 0.490 |
Why?
|
Endocrine Disruptors | 2 | 2017 | 237 | 0.490 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2008 | 705 | 0.480 |
Why?
|
Insemination | 3 | 2022 | 19 | 0.480 |
Why?
|
Eating | 3 | 2018 | 1526 | 0.480 |
Why?
|
Autoimmunity | 2 | 2020 | 1344 | 0.480 |
Why?
|
Female | 115 | 2024 | 378853 | 0.470 |
Why?
|
Clomiphene | 3 | 2021 | 72 | 0.460 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 708 | 0.460 |
Why?
|
Ovulation | 1 | 2014 | 190 | 0.450 |
Why?
|
Ovary | 4 | 2021 | 982 | 0.450 |
Why?
|
Sperm Injections, Intracytoplasmic | 5 | 2021 | 159 | 0.450 |
Why?
|
Adult | 84 | 2023 | 213394 | 0.440 |
Why?
|
Premature Birth | 5 | 2024 | 1702 | 0.440 |
Why?
|
Folic Acid | 4 | 2021 | 1297 | 0.420 |
Why?
|
Dietary Proteins | 1 | 2017 | 959 | 0.410 |
Why?
|
Superovulation | 1 | 2010 | 11 | 0.400 |
Why?
|
Body Mass Index | 6 | 2022 | 12655 | 0.390 |
Why?
|
Birth Weight | 7 | 2024 | 2062 | 0.380 |
Why?
|
Time-Lapse Imaging | 3 | 2020 | 195 | 0.370 |
Why?
|
Artificial Intelligence | 5 | 2023 | 2124 | 0.370 |
Why?
|
Cryopreservation | 4 | 2022 | 650 | 0.370 |
Why?
|
Retrospective Studies | 41 | 2023 | 76631 | 0.370 |
Why?
|
Hypothyroidism | 1 | 2014 | 659 | 0.350 |
Why?
|
Prolactinoma | 1 | 2010 | 113 | 0.340 |
Why?
|
Thyrotropin | 3 | 2020 | 849 | 0.340 |
Why?
|
Pregnancy Complications | 5 | 2015 | 2867 | 0.340 |
Why?
|
Humans | 125 | 2024 | 739398 | 0.340 |
Why?
|
Hyperprolactinemia | 1 | 2010 | 129 | 0.330 |
Why?
|
Paternal Exposure | 2 | 2021 | 89 | 0.330 |
Why?
|
Oocyte Retrieval | 5 | 2020 | 161 | 0.330 |
Why?
|
Prospective Studies | 38 | 2023 | 53037 | 0.320 |
Why?
|
Placenta Diseases | 2 | 2021 | 194 | 0.320 |
Why?
|
Environmental Exposure | 7 | 2023 | 4220 | 0.310 |
Why?
|
Turner Syndrome | 2 | 2021 | 130 | 0.300 |
Why?
|
Preimplantation Diagnosis | 2 | 2023 | 152 | 0.290 |
Why?
|
Chorionic Gonadotropin | 2 | 2023 | 475 | 0.290 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2022 | 1338 | 0.290 |
Why?
|
Embryo, Mammalian | 4 | 2022 | 1698 | 0.280 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2006 | 98 | 0.270 |
Why?
|
Diet | 8 | 2023 | 7876 | 0.270 |
Why?
|
Fertilization | 3 | 2021 | 196 | 0.270 |
Why?
|
Placenta | 4 | 2022 | 1682 | 0.260 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3217 | 0.250 |
Why?
|
Hirsutism | 1 | 2004 | 69 | 0.250 |
Why?
|
Hyperandrogenism | 1 | 2004 | 38 | 0.250 |
Why?
|
Models, Chemical | 1 | 2006 | 628 | 0.230 |
Why?
|
Oocytes | 5 | 2023 | 1185 | 0.230 |
Why?
|
Infertility, Male | 3 | 2021 | 408 | 0.220 |
Why?
|
Contraceptives, Oral | 1 | 2005 | 563 | 0.210 |
Why?
|
Sperm Count | 2 | 2023 | 216 | 0.210 |
Why?
|
Air Pollution | 3 | 2020 | 2268 | 0.210 |
Why?
|
Menstrual Cycle | 1 | 2005 | 550 | 0.200 |
Why?
|
Air Pollutants | 3 | 2020 | 2801 | 0.200 |
Why?
|
Alkanesulfonic Acids | 1 | 2024 | 172 | 0.200 |
Why?
|
Wounds, Penetrating | 4 | 1996 | 306 | 0.200 |
Why?
|
Laboratory Personnel | 1 | 2021 | 19 | 0.200 |
Why?
|
Logistic Models | 9 | 2020 | 13402 | 0.200 |
Why?
|
Preconception Care | 2 | 2019 | 135 | 0.200 |
Why?
|
Coitus | 1 | 2022 | 132 | 0.200 |
Why?
|
Pituitary Neoplasms | 1 | 2010 | 1334 | 0.200 |
Why?
|
Semen Preservation | 1 | 2021 | 35 | 0.200 |
Why?
|
Maternal Age | 2 | 2022 | 803 | 0.190 |
Why?
|
Treatment Outcome | 24 | 2022 | 62693 | 0.190 |
Why?
|
Boston | 10 | 2023 | 9314 | 0.190 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2021 | 31 | 0.190 |
Why?
|
Dietary Supplements | 5 | 2021 | 3279 | 0.190 |
Why?
|
Reproductive Medicine | 1 | 2022 | 108 | 0.190 |
Why?
|
Fetal Resorption | 1 | 2020 | 17 | 0.190 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3138 | 0.190 |
Why?
|
Arteriosclerosis | 1 | 2005 | 1092 | 0.190 |
Why?
|
Sulfones | 2 | 2021 | 436 | 0.190 |
Why?
|
Embryology | 1 | 2020 | 29 | 0.180 |
Why?
|
Maternal Mortality | 2 | 2013 | 312 | 0.180 |
Why?
|
Amino Acids | 1 | 2006 | 1727 | 0.180 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2023 | 482 | 0.170 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2012 | 255 | 0.170 |
Why?
|
Estradiol | 5 | 2023 | 2021 | 0.170 |
Why?
|
Mercury | 1 | 2021 | 282 | 0.170 |
Why?
|
Genetic Testing | 2 | 2023 | 3441 | 0.170 |
Why?
|
Fluorocarbons | 1 | 2024 | 443 | 0.170 |
Why?
|
Karyotyping | 1 | 2021 | 1241 | 0.170 |
Why?
|
Individuality | 1 | 2020 | 303 | 0.170 |
Why?
|
Neurofibromatosis 1 | 2 | 2014 | 558 | 0.170 |
Why?
|
Bayes Theorem | 3 | 2023 | 2303 | 0.160 |
Why?
|
Interleukin-6 | 1 | 2008 | 3194 | 0.160 |
Why?
|
Feeding Behavior | 2 | 2021 | 3180 | 0.160 |
Why?
|
Iodide Peroxidase | 1 | 2020 | 293 | 0.160 |
Why?
|
Women | 1 | 2020 | 230 | 0.160 |
Why?
|
Embryonic Development | 2 | 2021 | 701 | 0.160 |
Why?
|
Pregnancy Reduction, Multifetal | 1 | 1998 | 16 | 0.160 |
Why?
|
Thyroglobulin | 1 | 2018 | 114 | 0.160 |
Why?
|
Triplets | 1 | 1998 | 43 | 0.160 |
Why?
|
Clothing | 1 | 2018 | 92 | 0.160 |
Why?
|
Mosaicism | 1 | 2021 | 442 | 0.160 |
Why?
|
Flame Retardants | 1 | 2018 | 86 | 0.160 |
Why?
|
Thyroid Hormones | 1 | 2020 | 387 | 0.150 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 284 | 0.150 |
Why?
|
Risk Factors | 20 | 2022 | 71974 | 0.150 |
Why?
|
Reproductive History | 1 | 2018 | 209 | 0.150 |
Why?
|
Pregnancy, Ectopic | 1 | 2018 | 140 | 0.150 |
Why?
|
Automobiles | 1 | 2018 | 116 | 0.150 |
Why?
|
Pre-Eclampsia | 3 | 2023 | 1194 | 0.150 |
Why?
|
Ozone | 1 | 2020 | 468 | 0.150 |
Why?
|
Triclosan | 1 | 2017 | 55 | 0.150 |
Why?
|
Sperm-Ovum Interactions | 1 | 2016 | 24 | 0.150 |
Why?
|
Pesticide Residues | 1 | 2018 | 94 | 0.150 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4400 | 0.140 |
Why?
|
Spermatozoa | 1 | 2021 | 627 | 0.140 |
Why?
|
Climate Change | 1 | 2022 | 411 | 0.140 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2016 | 39 | 0.140 |
Why?
|
Plasticizers | 1 | 2016 | 47 | 0.140 |
Why?
|
Lifting | 1 | 2017 | 55 | 0.140 |
Why?
|
Triiodothyronine | 1 | 2018 | 491 | 0.140 |
Why?
|
Abdominal Abscess | 1 | 1998 | 153 | 0.140 |
Why?
|
Diet, Mediterranean | 2 | 2020 | 691 | 0.140 |
Why?
|
Dicarboxylic Acids | 1 | 2016 | 70 | 0.140 |
Why?
|
Diet Surveys | 2 | 2019 | 1165 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2021 | 8977 | 0.140 |
Why?
|
Academic Medical Centers | 3 | 2017 | 2749 | 0.140 |
Why?
|
Linear Models | 6 | 2017 | 5948 | 0.140 |
Why?
|
Infant, Newborn | 14 | 2024 | 25470 | 0.140 |
Why?
|
Soy Foods | 1 | 2016 | 44 | 0.140 |
Why?
|
Fallopian Tube Diseases | 1 | 2016 | 62 | 0.140 |
Why?
|
Oocyte Donation | 1 | 2016 | 49 | 0.140 |
Why?
|
Male | 40 | 2024 | 349022 | 0.140 |
Why?
|
Poisson Distribution | 1 | 2017 | 516 | 0.130 |
Why?
|
Laparotomy | 1 | 1998 | 472 | 0.130 |
Why?
|
Models, Molecular | 1 | 2006 | 5460 | 0.130 |
Why?
|
Sperm Motility | 3 | 2023 | 253 | 0.130 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2016 | 143 | 0.130 |
Why?
|
Fruit | 2 | 2019 | 1139 | 0.130 |
Why?
|
Calcifediol | 1 | 2016 | 166 | 0.130 |
Why?
|
Vegetables | 2 | 2019 | 1178 | 0.130 |
Why?
|
Seasons | 1 | 2021 | 1486 | 0.130 |
Why?
|
Testis | 1 | 2018 | 799 | 0.130 |
Why?
|
Temperature | 1 | 2021 | 2202 | 0.120 |
Why?
|
Thyroxine | 1 | 2018 | 666 | 0.120 |
Why?
|
Counseling | 1 | 2022 | 1526 | 0.120 |
Why?
|
Menotropins | 1 | 2014 | 45 | 0.120 |
Why?
|
Triglycerides | 1 | 2022 | 2447 | 0.120 |
Why?
|
Abdominal Injuries | 2 | 1996 | 351 | 0.120 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2013 | 31 | 0.120 |
Why?
|
von Hippel-Lindau Disease | 1 | 2015 | 153 | 0.120 |
Why?
|
Ureter | 1 | 1996 | 361 | 0.120 |
Why?
|
Wounds, Gunshot | 7 | 1996 | 562 | 0.120 |
Why?
|
Cohort Studies | 11 | 2023 | 40389 | 0.120 |
Why?
|
Biological Products | 1 | 2022 | 850 | 0.110 |
Why?
|
Housing | 1 | 2018 | 658 | 0.110 |
Why?
|
Vehicle Emissions | 1 | 2018 | 665 | 0.110 |
Why?
|
Dietary Fats | 2 | 2018 | 2013 | 0.110 |
Why?
|
Odds Ratio | 5 | 2018 | 9846 | 0.110 |
Why?
|
Cholesterol | 1 | 2022 | 2900 | 0.110 |
Why?
|
Caffeine | 1 | 2017 | 697 | 0.110 |
Why?
|
Work Schedule Tolerance | 1 | 2017 | 565 | 0.110 |
Why?
|
Risk Assessment | 6 | 2022 | 23294 | 0.110 |
Why?
|
Urine | 1 | 2013 | 370 | 0.100 |
Why?
|
Uterus | 1 | 2016 | 712 | 0.100 |
Why?
|
Wounds, Stab | 4 | 1995 | 71 | 0.100 |
Why?
|
Massachusetts | 6 | 2021 | 8669 | 0.100 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 24714 | 0.100 |
Why?
|
Neurofibromatosis 2 | 1 | 2015 | 381 | 0.100 |
Why?
|
Particulate Matter | 2 | 2020 | 2511 | 0.100 |
Why?
|
Antioxidants | 1 | 2019 | 1659 | 0.100 |
Why?
|
Weight Gain | 1 | 2021 | 2278 | 0.090 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 2010 | 53 | 0.090 |
Why?
|
Obesity | 2 | 2022 | 12643 | 0.090 |
Why?
|
Autoantibodies | 1 | 2018 | 2020 | 0.090 |
Why?
|
Ultrasonography | 3 | 2021 | 5941 | 0.090 |
Why?
|
Young Adult | 13 | 2021 | 56255 | 0.090 |
Why?
|
Prevalence | 3 | 2014 | 15153 | 0.090 |
Why?
|
Time Factors | 8 | 2021 | 40050 | 0.080 |
Why?
|
Gestational Age | 4 | 2021 | 3486 | 0.080 |
Why?
|
Occupational Diseases | 1 | 2017 | 1474 | 0.080 |
Why?
|
Organ Size | 1 | 2013 | 2247 | 0.080 |
Why?
|
Prognosis | 4 | 2020 | 28901 | 0.080 |
Why?
|
Nutritive Value | 2 | 2021 | 335 | 0.080 |
Why?
|
Luteal Phase | 1 | 2008 | 147 | 0.080 |
Why?
|
Prolactin | 1 | 2010 | 668 | 0.080 |
Why?
|
Leuprolide | 1 | 2009 | 303 | 0.080 |
Why?
|
Obstetric Labor, Premature | 3 | 2015 | 282 | 0.080 |
Why?
|
Regression Analysis | 1 | 2017 | 6452 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3817 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1327 | 0.070 |
Why?
|
Tuberous Sclerosis | 1 | 2015 | 1030 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2017 | 1791 | 0.070 |
Why?
|
Metabolome | 2 | 2023 | 881 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12328 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1058 | 0.070 |
Why?
|
Thrombosis | 1 | 2019 | 2961 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12237 | 0.070 |
Why?
|
Age Distribution | 2 | 2017 | 2904 | 0.070 |
Why?
|
Comorbidity | 2 | 2022 | 10362 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12948 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9812 | 0.060 |
Why?
|
Spinal Neoplasms | 1 | 2012 | 758 | 0.060 |
Why?
|
Tamoxifen | 1 | 2009 | 978 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 3945 | 0.060 |
Why?
|
Nurses | 1 | 2014 | 2455 | 0.060 |
Why?
|
Algorithms | 3 | 2021 | 13872 | 0.060 |
Why?
|
Radiography | 2 | 2010 | 6998 | 0.060 |
Why?
|
COS Cells | 1 | 2006 | 1159 | 0.060 |
Why?
|
Reproduction | 2 | 2021 | 666 | 0.060 |
Why?
|
Decision Making | 1 | 1998 | 3854 | 0.060 |
Why?
|
Colon | 3 | 1996 | 1771 | 0.060 |
Why?
|
Adolescent | 15 | 2021 | 85405 | 0.060 |
Why?
|
Middle Aged | 19 | 2021 | 212863 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16301 | 0.060 |
Why?
|
Micromanipulation | 1 | 2022 | 53 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 35326 | 0.050 |
Why?
|
Nutritional Status | 2 | 2021 | 1587 | 0.050 |
Why?
|
Ploidies | 1 | 2023 | 282 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 1721 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8431 | 0.050 |
Why?
|
Family Characteristics | 2 | 2018 | 997 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2010 | 6370 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3021 | 0.050 |
Why?
|
Vitamins | 2 | 2023 | 1602 | 0.050 |
Why?
|
Environmental Monitoring | 2 | 2019 | 1408 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1100 | 0.050 |
Why?
|
Testosterone | 2 | 2023 | 2391 | 0.050 |
Why?
|
Men | 1 | 2021 | 63 | 0.050 |
Why?
|
Hair | 1 | 2004 | 479 | 0.050 |
Why?
|
Registries | 2 | 2016 | 8039 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2004 | 2974 | 0.050 |
Why?
|
Phenol | 1 | 2021 | 43 | 0.050 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1497 | 0.050 |
Why?
|
Age Factors | 2 | 2016 | 18349 | 0.050 |
Why?
|
Cesarean Section | 3 | 2015 | 1371 | 0.050 |
Why?
|
Exercise | 1 | 2016 | 5591 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4660 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3701 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2022 | 296 | 0.040 |
Why?
|
Aneuploidy | 1 | 2023 | 533 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2881 | 0.040 |
Why?
|
Probability | 1 | 2004 | 2500 | 0.040 |
Why?
|
Weights and Measures | 1 | 2018 | 43 | 0.040 |
Why?
|
Hyperemesis Gravidarum | 1 | 1998 | 23 | 0.040 |
Why?
|
Diet Records | 1 | 2020 | 420 | 0.040 |
Why?
|
Colostomy | 2 | 1996 | 98 | 0.040 |
Why?
|
Fetal Growth Retardation | 2 | 2013 | 570 | 0.040 |
Why?
|
Fetal Death | 1 | 2000 | 446 | 0.040 |
Why?
|
Sterilization, Tubal | 1 | 2018 | 87 | 0.040 |
Why?
|
Waist Circumference | 1 | 2022 | 912 | 0.040 |
Why?
|
Nitrogen Dioxide | 1 | 2020 | 486 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2022 | 581 | 0.040 |
Why?
|
Cell Count | 1 | 2021 | 1833 | 0.040 |
Why?
|
New England | 1 | 2020 | 1021 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2018 | 38942 | 0.040 |
Why?
|
Delivery, Obstetric | 2 | 2012 | 914 | 0.040 |
Why?
|
Intrauterine Devices | 1 | 2018 | 119 | 0.040 |
Why?
|
Androgens | 1 | 2004 | 1270 | 0.040 |
Why?
|
Binding Sites | 1 | 2006 | 6113 | 0.040 |
Why?
|
Dystocia | 1 | 1997 | 34 | 0.040 |
Why?
|
Methylprednisolone | 1 | 1998 | 388 | 0.040 |
Why?
|
Beverages | 1 | 2022 | 817 | 0.040 |
Why?
|
Thoracotomy | 2 | 1995 | 365 | 0.040 |
Why?
|
Immunoglobulins, Thyroid-Stimulating | 1 | 2016 | 34 | 0.040 |
Why?
|
Self Report | 2 | 2018 | 3524 | 0.030 |
Why?
|
Pesticides | 1 | 2019 | 287 | 0.030 |
Why?
|
Hospitalization | 2 | 2015 | 10208 | 0.030 |
Why?
|
Patient Selection | 1 | 2008 | 4211 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6610 | 0.030 |
Why?
|
Progesterone | 1 | 2020 | 772 | 0.030 |
Why?
|
Phytoestrogens | 1 | 2016 | 60 | 0.030 |
Why?
|
Postoperative Complications | 1 | 1998 | 15194 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1804 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 873 | 0.030 |
Why?
|
Microscopy | 1 | 2020 | 899 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2018 | 1801 | 0.030 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2014 | 79 | 0.030 |
Why?
|
Birth Rate | 1 | 2016 | 169 | 0.030 |
Why?
|
Research | 1 | 2023 | 2001 | 0.030 |
Why?
|
Subclavian Vein | 1 | 1994 | 54 | 0.030 |
Why?
|
Medical Staff | 1 | 2014 | 43 | 0.030 |
Why?
|
Colectomy | 2 | 1996 | 681 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1460 | 0.030 |
Why?
|
Demography | 1 | 2018 | 1650 | 0.030 |
Why?
|
Shock | 1 | 1996 | 318 | 0.030 |
Why?
|
Protein Binding | 1 | 2006 | 9375 | 0.030 |
Why?
|
Subclavian Artery | 1 | 1994 | 129 | 0.030 |
Why?
|
Pylorus | 1 | 1993 | 85 | 0.030 |
Why?
|
Vena Cava, Inferior | 1 | 1996 | 432 | 0.030 |
Why?
|
Neck Injuries | 1 | 1994 | 152 | 0.030 |
Why?
|
Leadership | 1 | 2022 | 1349 | 0.030 |
Why?
|
Thoracic Injuries | 1 | 1995 | 270 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 1996 | 983 | 0.030 |
Why?
|
Hot Temperature | 1 | 2018 | 1358 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 1998 | 758 | 0.030 |
Why?
|
Computer Simulation | 1 | 2006 | 6237 | 0.030 |
Why?
|
Intraoperative Care | 1 | 1996 | 766 | 0.030 |
Why?
|
Heart Injuries | 1 | 1994 | 210 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3307 | 0.030 |
Why?
|
Medical Records | 1 | 2017 | 1413 | 0.020 |
Why?
|
Forecasting | 2 | 2000 | 2952 | 0.020 |
Why?
|
Workload | 1 | 2017 | 843 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2012 | 8791 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2017 | 928 | 0.020 |
Why?
|
Duodenum | 1 | 1993 | 481 | 0.020 |
Why?
|
Nephrectomy | 1 | 1996 | 1033 | 0.020 |
Why?
|
Neck | 1 | 1994 | 691 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2021 | 2711 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2587 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 1996 | 1184 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2020 | 11985 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2004 | 15036 | 0.020 |
Why?
|
Survival Rate | 4 | 2012 | 12761 | 0.020 |
Why?
|
Reoperation | 1 | 1998 | 4192 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2000 | 2394 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2013 | 867 | 0.020 |
Why?
|
Infant | 2 | 2021 | 34923 | 0.020 |
Why?
|
Animals | 3 | 2022 | 168368 | 0.020 |
Why?
|
Ultrasonography, Mammary | 1 | 2009 | 250 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10398 | 0.020 |
Why?
|
Preoperative Care | 1 | 1996 | 2238 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3609 | 0.020 |
Why?
|
Spinal Cord Injuries | 1 | 1995 | 932 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2004 | 21694 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2004 | 15511 | 0.020 |
Why?
|
United States | 3 | 2021 | 69573 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2014 | 1179 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 19220 | 0.020 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2009 | 699 | 0.020 |
Why?
|
Hemorrhage | 1 | 1996 | 3441 | 0.020 |
Why?
|
Mastectomy, Segmental | 1 | 2009 | 954 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1771 | 0.010 |
Why?
|
Wound Infection | 2 | 1996 | 240 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2009 | 1242 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2009 | 1516 | 0.010 |
Why?
|
Child | 5 | 2018 | 77033 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2009 | 20676 | 0.010 |
Why?
|
Androstane-3,17-diol | 1 | 2001 | 19 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5113 | 0.010 |
Why?
|
Cheek | 1 | 2001 | 62 | 0.010 |
Why?
|
Absorption | 1 | 2001 | 248 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2009 | 2183 | 0.010 |
Why?
|
Abbreviated Injury Scale | 1 | 2000 | 51 | 0.010 |
Why?
|
Dihydrotestosterone | 1 | 2001 | 188 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 3453 | 0.010 |
Why?
|
Fetal Monitoring | 1 | 2000 | 70 | 0.010 |
Why?
|
South Africa | 2 | 1996 | 1743 | 0.010 |
Why?
|
Gels | 1 | 2001 | 426 | 0.010 |
Why?
|
Monitoring, Physiologic | 2 | 2000 | 1735 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2009 | 2370 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 2001 | 708 | 0.010 |
Why?
|
Promethazine | 1 | 1998 | 29 | 0.010 |
Why?
|
Ovariectomy | 1 | 2001 | 660 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 2000 | 568 | 0.010 |
Why?
|
Mammography | 1 | 2009 | 2466 | 0.010 |
Why?
|
Aging | 1 | 2017 | 8613 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2000 | 1011 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2000 | 1004 | 0.010 |
Why?
|
Shock, Traumatic | 1 | 1996 | 22 | 0.010 |
Why?
|
Pregnancy in Diabetics | 1 | 1997 | 180 | 0.010 |
Why?
|
Brachial Plexus | 1 | 1997 | 165 | 0.010 |
Why?
|
Shoulder | 1 | 1997 | 299 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2009 | 10961 | 0.010 |
Why?
|
Multiple Trauma | 1 | 1996 | 366 | 0.010 |
Why?
|
Administration, Oral | 1 | 2001 | 3909 | 0.010 |
Why?
|
Methods | 1 | 1993 | 1132 | 0.010 |
Why?
|
Sternum | 1 | 1994 | 175 | 0.010 |
Why?
|
Postpartum Hemorrhage | 1 | 1997 | 259 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9387 | 0.010 |
Why?
|
Rectum | 1 | 1997 | 900 | 0.010 |
Why?
|
Abscess | 1 | 1995 | 605 | 0.010 |
Why?
|
Blood Vessels | 1 | 1996 | 1126 | 0.010 |
Why?
|
Mutation | 1 | 2014 | 29658 | 0.010 |
Why?
|
Hemodynamics | 1 | 2000 | 4197 | 0.010 |
Why?
|
Cause of Death | 1 | 2000 | 3564 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 1995 | 817 | 0.010 |
Why?
|
Morbidity | 1 | 1994 | 1763 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15070 | 0.010 |
Why?
|
Emergencies | 1 | 1995 | 1152 | 0.010 |
Why?
|
Wounds, Nonpenetrating | 1 | 1995 | 788 | 0.010 |
Why?
|
Pilot Projects | 1 | 2001 | 8275 | 0.000 |
Why?
|
Recurrence | 1 | 1998 | 8307 | 0.000 |
Why?
|
Fractures, Bone | 1 | 1997 | 1939 | 0.000 |
Why?
|
Length of Stay | 1 | 1995 | 6295 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 1995 | 7626 | 0.000 |
Why?
|